Collection of Tissue Samples for Cancer Research
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
-Patients who are being evaluated in the Developmental Therapeutics Clinic, (DTC)/MOB/CCR/NCI will be entered onto this screening and tissue procurement protocol for collection of tissue specimens.
Objectives:
-To obtain samples for research purposes from tests performed for clinical indications or research indications on other research protocols.
Eligibility:
-Patients who are being evaluated for and treated on protocols within the DTC/MOB/CCR/NCI.
Design:
- Specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols that a given patient is enrolled in.
- These procedures may include, but are not limited to, laboratory tests on blood, CSF, urine or other specimens; pulmonary function tests; subspecialty consultations; molecular diagnostics on tumor tissues; radiographic and nuclear medicine studies, which may require the administration of contrast or a radioisotope tracer; and needle or open biopsies for diagnostic purposes.
- Procedures will not be performed for the sole purpose of obtaining tissue specimens or biological fluids for research purposes. However, research samples for this protocol will be obtained from tests performed for clinical or research indications on other research protocols.
- Given the risks associated with any procedure, the procedure will be discussed in detail with the patients, including the side effects, prior to obtaining a separate consent for each procedure.
- Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), and bone marrow. These specimens will be stored with patient identifiers and used to perform only those research studies that are outlined in this protocol.
- A patient may remain on this study for a period of 1 month at a time. Once a patient is taken off study, he or she may be re-consented and enrolled at a later time to obtain another research specimen as part of this protocol.
| Condition |
|---|
|
Tissue Analysis |
| Study Type: | Observational |
| Official Title: | Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI) |
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Patients who are being evaluated for and treated on protocols within the NIH Clinical Center.
Ability to understand and willingness to sign a written informed consent document indicating their willingness to have their tissue or biologic fluid specimens used for research as outlined in this protocol.
Age greater than 18 years
EXCLUSION CRITERIA:
None
Contacts and Locations| Contact: Shivaani Kummar, M.D. | (301) 435-5402 | kummars@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: Shivaani Kummar, M.D. 301-496-4916 kummars@mail.nih.gov | |
| Principal Investigator: | Shivaani Kummar, M.D. | National Cancer Institute (NCI) |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00900198 History of Changes |
| Other Study ID Numbers: | 060213, 06-C-0213 |
| Study First Received: | May 9, 2009 |
| Last Updated: | April 6, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Tissue Collection Biospecimen Assay Development Tissue Acquisition Tissue Biopsies |
ClinicalTrials.gov processed this record on May 19, 2013